Technology

Unilever taps growth on skincare brand takeover

By BLOOMBERG
LONDON • Unilever agreed to buy skincare brand Tatcha, which makes creams based on a foundation of green tea, rice and algae, seeking to ...

Uber rival Bolt relaunches in London after 2-year exile

By BLOOMBERG
LONDON • Uber Technologies Inc rival Bolt, formerly known as Taxi fy, has relaunched in London — nearly two years after its operating ...

Two Vietnam payments start-ups set to merge

By BLOOMBERG
SINGAPORE • Two of Vietnam’s payments start-ups are merging to add scale in the market where cashless payments are booming. Vimo ...

Apple to buy Drive.ai in bid for more talents

By BLOOMBERG
SAN FRANCISCO • Apple Inc is preparing to buy start-up Drive.ai in a small deal that will bring more engineers with experience in ...

Over 2,900 cyber security cases filed in January to April period

By RAHIMI YUNUS / Graphic By TMR
A TOTAL of 2,977 cyber security incidents involving fraud, intrusion and malicious code have been recorded between ...

Malaysia to use Huawei tech ‘as much as possible’, says Dr M amid US ban

By NG MIN SHEN / Pic By MUHD AMIN NAHARUL
Malaysia will continue to use Huawei Technologies Co Ltd’s technology “as much as possible”, Prime Minister ...

VW to alter battery plan as Samsung deal at risk

By BLOOMBERG
FRANKFURT • Volkswagen AG (VW) is reworking its battery- purchasing plan worth about €50 billion (RM234.5 billion) over concerns a supply ...

Tencent’s China Literature sinks amid crackdown

By BLOOMBERG
SHANGHAI • One of Tencent Holdings Ltd’s most valuable investments is sinking as China expands its crackdown on online content. China ...

Mexico reverses some cuts, hospitals to see dire shortages

By BLOOMBERG
MEXICO CITY • Mexico’s federal government has partially reversed budget cuts of about US$130 million (RM546 million) for its healthcare ...

Germany’s First Sensor receives offer from TE Connectivity

By BLOOMBERG
NEW YORK • First Sensor AG said it received an offer from TE Connectivity Ltd. “First Sensor has received a legally non-binding expression ...

An RM8.8m drug for deadly childhood disease approved by FDA

The US FDA approves Novartis’ Zolgensma, a gene therapy targeting children under 2 years old who have a severe illness called SMA
By BLOOMBERG LONDON • ...

Universal said to eye industry bidder as buyout firms balk

By BLOOMBERG
LOS ANGELES • Vivendi SA is targeting strategic buyers for a stake in Universal Music Group (UMG) as some private equity (PE) investors ...